XORTX Therapeutics Inc (XRTX)
2.61
-0.07
(-2.61%)
USD |
NASDAQ |
May 10, 16:00
2.61
0.00 (0.00%)
After-Hours: 20:00
XORTX Therapeutics Total Liabilities (Quarterly): 0.8259M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.8259M |
| September 30, 2023 | 0.5538M |
| June 30, 2023 | 0.4033M |
| March 31, 2023 | 0.5998M |
| December 31, 2022 | 5.369M |
| September 30, 2022 | 3.111M |
| June 30, 2022 | 2.950M |
| March 31, 2022 | 4.038M |
| December 31, 2021 | 4.156M |
| September 30, 2021 | 9.464M |
| June 30, 2021 | 3.237M |
| March 31, 2021 | 3.784M |
| December 31, 2020 | 0.811M |
| September 30, 2020 | 0.743M |
| June 30, 2020 | 0.6376M |
| March 31, 2020 | 0.825M |
| December 31, 2019 | 0.995M |
| September 30, 2019 | 0.8891M |
| June 30, 2019 | 0.8122M |
| Date | Value |
|---|---|
| March 31, 2019 | 0.7234M |
| December 31, 2018 | 0.6929M |
| September 30, 2018 | 0.694M |
| June 30, 2018 | 0.6301M |
| March 31, 2018 | 0.6364M |
| December 31, 2017 | 0.9107M |
| November 30, 2017 | 0.0062M |
| September 30, 2017 | 0.6889M |
| August 31, 2017 | 0.0056M |
| May 31, 2017 | 0.0067M |
| February 28, 2017 | 0.0103M |
| November 30, 2016 | 0.0069M |
| August 31, 2016 | 0.0513M |
| May 31, 2016 | 0.0162M |
| February 29, 2016 | 0.0062M |
| November 30, 2015 | 0.0063M |
| August 31, 2015 | 0.0999M |
| May 31, 2015 | 0.0694M |
| February 28, 2015 | 0.0481M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.4033M
Minimum
Jun 2023
9.464M
Maximum
Sep 2021
2.326M
Average
0.8891M
Median
Sep 2019
Total Liabilities (Quarterly) Benchmarks
| ImmunoPrecise Antibodies Ltd | 21.54M |
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
| Lexaria Bioscience Corp | 0.2042M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.468M |
| Shareholders Equity (Quarterly) | 4.642M |